%0 Journal Article
%B Lancet
%D 2012
%G eng
%M 22632908
%P 2352-63
%T The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
%V 379
%2 3386495
%7 2012/05/29
%@ 1474-547X (Electronic)0140-6736 (Linking)